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Treating viral illnesses or noninfective causes of inﬂammation with antibiotics is ineﬀective and contributes to the development of
antibiotic resistance, toxicity, and allergic reactions, leading to increasing medical costs. A major factor behind unnecessary use of
antibiotics is, of course, incorrect diagnosis. For this reason, timely and accurate information on whether the infection is bacterial
inorigin would behighlybeneﬁcial. Inthis paper wewill present ourrecent studieson theexpression ofopsonin receptors onpha-
gocytes. The analysis of the expression levels of FcγRI, CR1, and CR3, along with CRP and ESR data, provides a novel application
to the diagnosis of infectious and inﬂammatory diseases. The best clinical beneﬁt will be obtained when the individual variables
are combined to generate the CIS point method for a bacterial infection marker, DNAVS point for diﬀerentiating between DNA
and RNA virus infections, and CRP/CD11b ratio for a marker of Gram-positive sepsis.
1.Introduction
There are two basic molecular mechanisms of recognition of
microorganisms by phagocytic cells: opsonin-dependent,
and opsonin-independent. The former mechanism requires
serum components, opsonins, which act by binding to the
surface of the microorganisms at one end and to speciﬁc re-
ceptors on the phagocyte surface at the other. The best-
known opsonins are Immunoglobulin G (IgG) which binds
via its Fc domain to the Fc receptor (FcR) on the phagocytes,
and the C3b and iC3b fragments of the C3 component of
complement, which bind to the complement receptors CR1
and CR3, respectively, on the phagocyte surface. Many dif-
ferent types of bacteria interact with phagocytic cells in
serum-free media in vitro in the absence of opsonins, Cer-
tain integrins (CR3 among others) serve as receptors for
microbial surface ligands in nonopsonic phagocytosis [1].
IgG is the most abundant Ig class in serum, constituting
over 75% of circulating immunoglobulin. It mediates key
eﬀector functions through interaction with Fcγ receptors.
Fcγ receptors are divided generally into three main classes,
FcγRI(CD64), FcγRII (CD32), and FcγRIII (CD16), each
with distinct structural and functional properties. FcγRI is a
high-aﬃnity receptor for monomeric IgG (Ka:1 0 9–1010/M)
with three extracellular Ig-like domains expressed constitu-
tively by monocytes and macrophages, as well as by many
myeloid progenitor cells. In contrast to FcγRI, the other two
classesofFcγ receptor,FcγRIIandFcγRIII,displaylowaﬃni-
ty for monomeric IgG. They are capable of binding to aggre-
gated IgG through multimeric low-aﬃnity, high-avidity in-
teractions, which are particularly important in the recogni-
tion and binding of antibody-antigen complexes during an
immune response. IgG binding to low-aﬃnity FcγRc a nt ri g -
ger a range of eﬀector and immunoregulatory functions, in-
cluding degranulation, phagocytosis, and regulation of anti-
body production. FcγRII is expressed by diverse cell types:
FcγRIIa isoform by myeloid cells, including polymorphonu-
clear leucocytes, monocytes, macrophages, platelets, and cer-
tain types of endothelial cells and, FcγRIIb by B cells, mono-
cytes, and macrophages, while FcγRIIc expression is restri-
cted solely to natural killer (NK) cells. The other low-af-
ﬁnity Fcγ receptor, FcγRIII, is in two isoforms. Although2 The Scientiﬁc World Journal
FcγRIIIa and FcγRIIIb share high levels of sequence homol-
ogy, they exhibit distinct structural diﬀerences. FcγRIIIa is
a transmembrane protein that associates with the FcγR
chain, whereas FcγRIIIb is processed posttranslationally as a
glycosylphosphatidylinositol- (GPI-)anchored protein, lack-
ing transmembrane and intracellular domains. The FcγRIIIa
isoform is expressed widely by several leucocyte cell types,
including macrophages, NK cells, and subsets of T cells and
monocytes,whileFcγRIIIbisexpressedconstitutivelyonlyby
neutrophils [2].
The receptors for complement molecules, designated
complement receptors 1 (CD35) and 3 (CD11b), present on
all phagocytic cells, are only weakly expressed on the sur-
face of resting neutrophils and are mostly stored in intracell-
ular granules (CD35 in secretory vesicles and CD11b in both
speciﬁc and gelatinase granules and secretory vesicles). Sec-
retory vesicles (SV) are the most likely to release contents via
degranulation,followedbygelatinase,speciﬁc,andazurophil
granules. In addition to exposure to proinﬂammatory cyto-
kines, even relatively simple physical stress, diﬀerent antico-
agulant types, temperature changes, and isolation of leuko-
cytes can trigger rapid degranulation of neutrophil SVs. Fus-
ion of SVs with the plasma membrane leads to increased
CD35 and CD11b levels at the cell surface [3].
Do the infectious and other inﬂammatory diseases in-
duce alterations in the expression of the opsonin receptors
of phagocytes?
2. Receptor ExpressionMeasurements
Erythrocytes were lysed in anticoagulated blood by adding
10 volumes of 0.83%NH4Cl followed by 15min of incuba-
tionatroomtemperature.Leukocyteswereseparatedbycen-
trifugation. Before the measurements of receptor expression,
leukocytes (3 × 105) were incubated in 50μL of gHBSS with
monoclonal antibodies (0.4μg) in polystyrene ﬂow cyto-
m e t e rv i a l sf o r3 0 m i na t+ 4 ◦C. After incubation, the cells
were washed once with cold gHBSS and resuspended in
cold gHBSS. Leukocytes incubated with mouse unspeciﬁc
immunoglobulins served as controls for correction of leuko-
cyte autoﬂuorescence. A relative measure of receptor expres-
sion was obtained by determining the mean ﬂuorescence in-
tensity of 5000 leukocytes. In the case of neutrophil FcγRI,
the percentage of ﬂuorescence positive cells (%) was also
determined. In neutrophils, which express only few FcγRI
(MFI < 4.0) on the cell membrane, the %-value varied bet-
ween 5 and 70 which described the changes in expression
levels better than the MFI. At a high expression levels (MFI
value > 4.0), the %-value was 95–100. When %-value was
100 regardless of the activation state of leukocyte (i.e., in the
case of CR1, CR3, and FcγRII in neutrophils, monocytes,
andeosinophils, FcγRIinmonocytes,andFcγRIIIinneutro-
phils), only MFI was presented. Measurement of leukocyte
receptorexpressionwasperformedusingﬂuorescently(FITC
or PE) labelled receptor-speciﬁc monoclonal antibodies. The
receptor panel studied for two-colour immunoﬂuorescence
analysis and the mAbs are presented in Table 1.
Table 1: Monoclonal antibodies used in receptor expression stud-
ies.
Clone Conjugate Speciﬁcity CD group Isotype
FcγRs
22 FITC FcγRI CD64 IgG mouse
2E1 PE FcγRII CD32 IgG2a mouse
3G8 FITC FcγRIII CD16 IgG1 mouse
CRs
J3D3 FITC CR1 CD35 IgG1 mouse
Bear1 PE CR3 CD11b IgG1 mouse
Isotype controls
679.1Mc7 FITC/PE Irrelevant — IgG1 mouse
U7.27 PE Irrelevant — IgG2a mouse
Table 2: Receptor expression changes in various diseases compared
to healthy controls.
Receptor Bacterial
infection
Viral
infection
Kidney
cancer
Atopic
dermatitis
Neutrophils
CR1/CD35 +++ (−) no change +
CR3/CD11b +++ + ++ (+)
FcγRI/CD64 +++ +++ (+) no change
FcγRII/CD32 + (−) no change (+)
FcγRIII/CD16 (−) no change no change (−)
Monocytes
CR1/CD35 +++ ++ + (+)
CR3/CD11b +++ ++ +++ (+)
FcγRI/CD64 +++ +++ + (−)
FcγRII/CD32 (+) no change ++ (+)
The +/− without parentheses indicates a signiﬁcant increase/decrease in the
expression of receptor in question compared to healthy control.
The +/− in parentheses represents an insigniﬁcant increase/decrease in the
expression of receptor in question compared to healthy control.
+o r−=0%–50% increase or decrease compared to healthy control, ++ =
50%–100% increase compared to healthy control, and +++ = more than
100% increase compared to healthy control.
3. Receptor ExpressioninHealth andDiseases
Earlier, we have performed few studies where we have
measured the receptor expression in various rather small
patient groups [4–7]. The summary of the results from these
studies is presented in Table 2. In monocytes, all the recep-
tors were upregulated in bacterial and viral infections. In
neutrophils, CR1, CR3, FcγRI, and FcγRII were upregulated,
while FcγRIII was downregulated in bacterial infections.
CR1 and FcγRII were downregulated, while CR3 and FcγRI
were upregulated in viral infections. These results led us to
concludethatthereceptorexpressioncouldbeusedasabasis
for the diﬀerential diagnosis of bacterial and viral infections.
4. ProspectiveStudy
In this study, standard clinical laboratory data (neutrophil
count, serum C reactive protein level (CRP), and erythrocyteThe Scientiﬁc World Journal 3
Rheumatoid arthritis
Mean (SD) age: 59 (17) years
(8 women and 13 men)
Carcinoma
Kidney tumor
Shoulder fracture
Nephritis
Panniculitis
Ulcerative colitis
Subacute thyroiditis
Postpericardiotomy syndrome
Temporal arteritis
Collagen disease
Reactive arthritis
Still’s disease
n
4
3
3
2
1
1
1
1
1
1
1
1
1
292 prospectively collected heparin 
blood samples from febrile patients
136 excluded samples
61 patients receiving corticosteroids or 
hospitalised over three days before procuring 
blood samples
75 patients with uncertain clinical diagnosis,
Mean (SD) age: 38 (17) years
(13 women and 25 men)
21 DNA virus infections
Varicella zoster virus (VZV)/(HHV-3)
(chickenpox (n = 6), shingles (n = 3))
Hepatitis B virus  (hepatitis)
17 RNA virus infections
Enterovirus  (meningitis)
Dengue virus  (dengue fever)
(HHV = human herpesvirus)
Epstein-Barr virus (EBV)/(HHV-4) (mononucleosis)
Cytomegalovirus (CMV)/(HHV-5) (mononucleosis)
Adenovirus (upper respiratory tract infection)
Herpes simplex virus (HSV)/(HHV-1 or 2) (meningitis)
Inﬂuenza A (upper respiratory tract infection)
Tick-borne encephalitis virus (TBEV) (encephalitis)
Puumala virus (epidemic nephropathy)
n Family
Herpesviridae
Herpesviridae
Herpesviridae
Hepadnaviridae
Adenoviridae
Herpesviridae
Orthomyxoviridae
Picornaviridae
Flaviviridae
Flaviviridae
Bunyaviridae
9
9
7
2
2
1
1
1
1
1
4
Mean (SD) age: 59 (17) years
(19 women and 24 men)
Pneumonia 
Erysipelas
Clinical sepsis syndrome 
Cellulitis
Pleural empyema 
Pyelonephritis 
Cholecystitis
Mean (SD) age: 44 (23) years
(3 women and 5 men)
Upper respiratory tract infection 
Meningitis 
Pneumonia
n
23
11
3
3
1
1
1
6
1
1
Mean (SD) age: 34 (12) years
(33 women and 27 men)
Mean (SD) age: 50 (17) years
(23 women and 23 men)
n Etiologic agents
Sepsis (27) 10
7 Escherichia coli
3 Staphylococcus aureus
2
1 Salmonella species
1 Klebsiella oxytoca
1
1
1
Peptostreptococcus
Escherichia coli
1
Enteritis 2
Pneumonia 1 Legionella pneumophila
1
Multiple skin abscesses 1
1
Staphylococcus aureus
Staphylococcus aureus
Abscess in liver 1
1
1 Escherichia coli, Pseudomonas
Pyelonephritis (10) 9
Abscess in back
Pleural empyema
Wound infection
Streptococcus pneumoniae
Enterococcus faecalis
Streptococcus pyogenes
S. intermedius and S. oralis
Enterococcus faecalis
Campylobacter jejuni
Streptococcus pneumoniae
Fusobacterium species
Streptococcus pyogenes
aeruginosa, Enterococcus faecalis,
and Bacteroides fragilis
Escherichia coli and
Microbiologically conﬁrmed bacterial infections (n = 46) n = 43)
Healthy controls (n = 60)
Clinically diagnosed viral infections (n = 8)
Clinically diagnosed bacterial infections (
Inﬂammatory diseases (n = 21)
Microbiologically conﬁrmed viral infections (n = 38)
Figure 1: Subgroups of patients. Subgroup classiﬁcation was based on medical and microbiological examination, including bacterial cul-
tures, serological assays, and identiﬁcation of microbial antigens or nucleic acids from nasopharyngeal, urine, cerebrospinal ﬂuid, or blister
specimens. The healthy volunteer control group is also deﬁned. Parentheses include the number of presented cases.4 The Scientiﬁc World Journal
0
1
2
3
4
5
6
7
8
12
16
20
24
28
32
36
40
44
48
Other three variables:
(1) TNCR index (ROC curve cutoff value = 3.4 and additional second cutoﬀ value = 3.9; sensitivity (%)/speciﬁcity (%) = 92/89)
(2) CRP (ROC curve cutoff value = 77 mg/L and additional second cutoﬀ value = 161 mg/L; sensitivity (%)/speciﬁcity (%) = 88/85)
(3) ESR (ROC curve cutoff value = 28 mm/h and additional second cutoﬀ value = 48 mm/h; sensitivity (%)/speciﬁcity (%) = 88/89)
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Figure 2: Formation of clinical infection score (CIS) point.
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(3) Neutrophil CD64% (ROC curve cutoff value = 82% and additional second cutoﬀ value = 96)
Figure 3: Formation of DNA virus score (DNAVS) point.
sedimentation rate (ESR)) and quantitative ﬂow cytometric
analysis of neutrophil complement receptors, CR1 and CR3,
aswellas FcγRI(CD64) were obtained from292 hospitalized
febrile patients. After microbiological conﬁrmation or clini-
caldiagnosis,135patientswerefoundtohaveeitherbacterial
(n = 89) or viral (n = 46) infection. The patient data was
compared to 60 healthy controls. The grouping of the pa-
tients into subgroups is presented in Figure 1.T h em e a no f
parameters measured in the patient samples are presented in
Table 3. The average expression levels of CR1 and CR3 onThe Scientiﬁc World Journal 5
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Figure 4: FcγRI/CIS point bivariate dot-plot graph.
neutrophils in bacterial infections were over threefold and
twofold higher, respectively, compared with viral infections
and controls. According to receiver operating characteristic
(ROC) curve analysis, neutrophil CR1 displayed 92% sensi-
tivity and 85% speciﬁcity in distinguishing between bacterial
and viral infections (Figure 2(a)). Compared with other
measured variables, such as neutrophil CR3, neutrophil
count, CRP, and ESR, neutrophil CR1 had the most eﬀective
diﬀerential capacity. The lower diagnostic accuracy of CR3
compared with CR1 may be explained by the phenomenon
that CR3 is expressed not only from rapidly releasing secre-
tory vesicles like CR1, but also from speciﬁc and gelatinase
granules [8]. The diﬀerential capacity of CR1 and CR3 was
lost when EDTA, instead of heparin, was used as an antico-
agulant (Table 3) due to defaults in extracellular calcium in
blood samples. The behaviour of CRP and ESR was similar
to the expression of neutrophil CR1 in that they were signi-
ﬁcantly higher in bacterial than in viral infections. In addi-
tion to the measured variables, we deﬁned a computational
variable by multiplying the neutrophil count, mean ﬂuo-
rescence intensity (MFI) of FITC-conjugated CR1-speciﬁc
monoclonal antibodies on neutrophils and MFI of PE-con-
jugated CR3-speciﬁc monoclonal antibodies on neutrophils
(= neutrophil count × relative number of CR1 on neutro-
phils × relative number of CR3 on neutrophils). The index
obtainedbytakingthebase-10logarithmofthisfactorialrep-
resents the total number of neutrophil complement recep-
tors per blood sample volume (TNCR index, Table 3.) The
TNCR index has somewhat higher speciﬁcity (89% versus
85%) than neutrophil CR1 in distinguishing between bacte-
rial and viral infections [9].
5.DistinguishingbetweenBacterialand
ViralInfectionswith the Clinical
Infection Score (CIS) Point [9,10]
To determine whether the diagnostic yield of measured indi-
vidual variables increases upon combination, we estimated
the clinical infection score (CIS) point consisting of four var-
iables, including CRP (ROC curve cutoﬀ point=77mg/L),
ESR (28mm/h), mean amount of CR1 on neutrophil (MFI
of 8.7) and TNCR index (3.4). For every variable measured,
a result less than the cutoﬀ point was converted to a variable
score point of 0, that between the cutoﬀ point and an
additional second cutoﬀ value (161mg/l for CRP, 42mm/h
for ESR, MFI of 13.5 for CR1 and 3.9 for TNCR index),
was converted to a variable score point of 1, and that greater
than the additional second cutoﬀ point value was converted
to a variable score point of 2 (Figure 2(a)). An additional
second cutoﬀ value of a variable was the maximum value
detected in patients with viral infection. The maximum virus
value of higher than the average value of bacterial infection
(epidemic nephropathy, ESR of 112mm/h) was ignored
whenadditionalsecondcutoﬀvalueswereputintheirplaces.
We obtained CIS points that varied between 0 and 8 by
combining variable scores (Figure 2(b)). At a cutoﬀ point
of >2, the CIS points diﬀerentiated between microbiologi-
cally conﬁrmed bacterial infection (n = 46) and viral infec-
tion (n = 38) with 98% sensitivity and 97% speciﬁcity [9].
6.DistinguishingbetweendsDNA andssRNA
VirusInfectionswith the DNA Virus
Score (DNAVS) Point [11]
Similarly to CIS point, we estimated the DNA virus score
(DNAVS) point consisting of four variables, including mean
amount of CD64 on neutrophil (ROC curve cutoﬀ point =
MFI of 1.7), neutrophil CD64% (82%), percent of lympho-
cytes (29%), and lymphocyte count (1.9 × 109/L). For every
variable measured, a result less than the cutoﬀ point was
converted to a variable score point of 0, that between the
cutoﬀ point and an additional second cutoﬀ value (MFI of
2.5 for CD64, 96% for neutrophil CD64%, 56% for percent
of lymphocytes, and 2.8 × 109/l for lymphocyte count) was
converted to a variable score point of 1, and that greater
than the additional second cutoﬀ point value was converted
to a variable score point of 2. An additional second cutoﬀ
value of a variable was the maximum value detected in
patients with ssRNA virus infection (Figure 3). After data
conversion, we obtained SUM that varied between 0 and
8 by adding four variable score points together. Next, we
deﬁned a DNAVS point by multiplying the SUM, CD646 The Scientiﬁc World Journal
Table 3: Parameters measured in the patient material expressed as mean (S.D.). Receptor expression data from both heparin and EDTA
anticoagulated blood samples are presented.
Microbiologically conﬁrmed Clinically diagnosed
Bacterial infection Viral infection Healthy control Bacterial infection Viral infection
Variables (n = 46) (n = 38) (n = 60) (n = 43) (n = 8)
CRP (mg(L) 232 (135) 40 (41) — 217 (103) 43 (49)
ESR (mm/h) 65 (28) 19 (19) — 69 (27) 22 (15)
WBC (×109/L) 11 (4.9) 7.7 (4.1) 4.8 (1.3) 9.8 (4.8) 5.9 (1.4)
PMNL (%) 71 (14) 51 (22) 51 (9.8) 74 (13) 49 (20)
PMNL (×109/L) 8.2 (3.6) 3.5 (2.0) 2.6 (0.9) 7.5 (3.9) 2.6 (1.0)
Heparin sample:
Neutrophil CR1 21 (9.9) 5.7 (2.9) 6.3 (2.2) 20 (7.5) 6.4 (3.3)
Neutrophil CR3 100 (51) 54 (23) 49 (18) 104 (45) 59 (35)
TNCR index 4.1 (0.5) 2.9 (0.5) 2.8 (0.3) 4.0 (0.5) 2.9 (0.5)
CIS point 6.2 (1.7) 0.6 (1.0) — 6.3 (1.9) 0.6 (1.2)
EDTA sample (n = 15) (n = 6) (n = 18)
Neutrophil CR1 8.3 (2.4) 6.2 (2.8) 4.8 (1.3) — —
Neutrophil CR3 34 (12) 36 (11) 28 (6.0) — —
factor (CF), and haematopoietic factor (HF) (DNAVS point
=SUM×CF×HF). CF of 0.25 was used when variable score
point of both receptor variables was 0. If variable score point
of both haematopoietic variables was 0, then HF of 0.5 was
used. In all the other cases, CF and HF were 1. At a cutoﬀ
point of higher than or equal to 1.5, the DNAVS points
diﬀerentiated between dsDNA and ssRNAvirus infections
with 95% sensitivity and 100% speciﬁcity [11].
7.DistinguishingbetweenBacterial
Infections, ViralInfectionsand
InﬂammatoryDiseases withthe Analysis
of FcγRI Expression[12–14]
The average number of FcγRI on the surfaces of both
neutrophils and monocytes was signiﬁcantly increased in
patients with febrile viral and bacterial infections, compared
tohealthy controls.Furthermore, we describe a novel marker
of febrile infection, designated “CD64 score point”, which
incorporates the quantitative analysis of FcγRI expressed
on both neutrophils and monocytes, with 94% sensitivity
and 98% speciﬁcity in distinguishing between febrile infec-
tions and healthy controls. By contrast, analysis of FcγRI
expression on neutrophils and monocytes displayed poor
sensitivity (73% and 52%) and speciﬁcity (65% and 52%) in
distinguishing between bacterial and viral infections, and the
levels did not diﬀer signiﬁcantly between systemic (sepsis),
local, and clinically diagnosed bacterial infections. Thus, the
increased number of FcγRI on neutrophils and monocytes is
a useful marker of febrile infection but cannot be applied for
diﬀerential diagnosis between bacterial and viral infections
or between systemic and local bacterial infections [12].
As noticed above, the expression of neutrophil CD35 is
higherinbacterialthaninviralinfections.NeutrophilCD35-
based diﬀerentiation between bacterial and viral infections
can be improved by generating the CIS point. We further
developed CD64/CIS point bivariate dot-plot graph (Figures
4(a)–4(d)), where the vertical and horizontal lines are set
to represent the optimal cutoﬀ point, MFI value of 1.5 for
neutrophil FcγRI and 2.5 for CIS point value, respectively.
The bivariate dot-plot graph can be divided into four quad-
rants: upper left quadrant (ULQ), upper right quadrant
(URQ), lower left quadrant (LLQ), and lower right quadrant
(LRQ). Now, 92% of bacterial infections are located in URQ
whereas viral infections are located in LLQ (35%) or in LRQ
(61%). Inﬂammatory diseases distributed to LLQ (14%),
ULQ (43%), and URQ (43%) [13].
8.DetectingGram-PositiveSepsis[15]
In Gram-negative bacterial infection (n = 21), the average
amount of CD11b on neutrophils was signiﬁcantly higher
than in gram-positive bacterial infection (n = 22). On the
contrary,CRPlevelwassigniﬁcantlyhigherinGram-positive
than in gram-negative bacterial infection. By dividing the
serum CRP value by the amount of CD11b on neutro-
phils, we derived a novel marker of Gram-positive sepsis,
CRP/CD11b ratio, which displayed 76% sensitivity and 80%
speciﬁcity for the detection of Gram-positive sepsis (n = 17)
among febrile patients with microbiologically conﬁrmed or
clinically diagnosed bacterial infection.
9. Conclusion
Treating viral illnesses or noninfective causes of inﬂamma-
tion with antibiotics is ineﬀective and contributes to the
development of antibiotic resistance, toxicity and allergic
reactions, leading to increasing medical costs. A major factor
behind unnecessary use of antibiotics is, of course, incorrect
diagnosis. For this reason, timely and accurate information
on whether the infection is bacterial in origin would be
highly beneﬁcial in the ﬁght against antibiotic resistance.The Scientiﬁc World Journal 7
The analysis of the expression levels of FcγRI, CR1, and CR3,
along with CRP and ESR data, provides a novel application
tothediagnosisofinfectiousandinﬂammatorydiseases.The
best clinical beneﬁt from the quantitative analysis of these
markers will be obtained when the individual variables are
combined to generate the CIS point method for a reliable
bacterial infection marker, DNAVS point for diﬀerentiating
between DNA andRNA virus infections, CD 64 score point
for a marker of febrile infection and CRP/CD11b ratio for a
marker of gram-positive sepsis.
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